Pays: Australie
Langue: anglais
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
VITAMIN B12A = HYDROXOCOBALAMIN; ERYSIPELOTHRIX RHUSIOPATHIAE; CLOSTRIDIUM CHAUVOEI - TOXOID; CLOSTRIDIUM NOVYI TYPE B - TOXOID; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID; CLOSTRIDIUM SEPTICUM - TOXOID; CLOSTRIDIUM TETANI - TOXOID; CORYNEBACTERIUM PSEUDOTUBERCULOSIS (OVIS) - TOXOID; THIOMERSAL
ZOETIS AUSTRALIA PTY LTD
MISC. VACCINES OR ANTI SERA
VITAMIN B12A = HYDROXOCOBALAMIN VITAMIN-B12 Active 2.0 mg/ml; ERYSIPELOTHRIX RHUSIOPATHIAE VACCINE-GENERAL Active 40.0 IU/vial; CLOSTRIDIUM CHAUVOEI - TOXOID VACCINE-TOXOID Active 0.0 Ph.Eur.; CLOSTRIDIUM NOVYI TYPE B - TOXOID VACCINE-TOXOID Active 3.5 IU/ml; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID VACCINE-TOXOID Active 5.0 IU/ml; CLOSTRIDIUM SEPTICUM - TOXOID VACCINE-TOXOID Active 2.5 IU/ml; CLOSTRIDIUM TETANI - TOXOID VACCINE-TOXOID Active 2.5 IU/ml; CORYNEBACTERIUM PSEUDOTUBERCULOSIS (OVIS) - TOXOID VACCINE-TOXOID Active 6.0 CPU/ml; THIOMERSAL MERCURY Other 0.1 mg/ml
250 mL; 500 mL
VM - Veterinary Medicine
IMMUNOTHERAPY
Poison schedule: 0; Withholding period: MEAT: Zero (0) days MILK: Zero (0) days EXPORT SLAUGHTER INTERVAL (ESI): Zero ( 0) days; Host/pest details: SHEEP: [BLACK DISEASE, BLACKLEG, CASEOUS LYMPHADENITIS (CHEESY GLAND), ENTEROTOXAEMIA (PULPY KIDNEY), ERYSIPELOTHRIX ARTHRITIS, MALIGNANT OEDEMA, TETANUS, VITAMIN B12 DEFICIENCY]; SHEEP RAM (MALE): [SWELLED HEAD]
Registered
2023-07-01
GlanEry 7 in 1 B12 Vaccine for Sheep 89053 / 123515 Product Name: APVMA Approval No: Label Name: GlanEry 7 in 1 B12 Vaccine for Sheep Signal Headings: FOR ANIMAL TREATMENT ONLY Constituent Statements: Corynebacterium pseudotuberculosis (ovis) ≥ 6 CPU/mL, Clostridium perfringens type D ≥ 5 IU/mL, C. tetani ≥ 2.5 IU/mL, C. novyi type B ≥ 3.5 IU/mL, C. septicum ≥ 2.5 IU/mL (as ultrafiltered toxoids), C. chauvoei (meets Ph. Eur.), Erysipelothrix rhusiopathiae ≥ 40 IU/ dose (as formol cultures), 2 mg/mL hydroxocobalamin. Also contains: 0.1 mg/mL thiomersal (preservative) Claims: For the active immuni s ation of sheep to prevent mortality or clinical signs associated with enterotoxaemia (pulpy kidney), tetanus, black disease, swollen head in rams, malignant oedema and blackleg; to reduce the clinical signs and lesions associated with caseous lymphadenitis (CLA or cheesy gland); to reduce clinical signs of erysipelas arthritis. For the treatment and prevention of Vitamin B12 deficiency in sheep, in areas of known or suspected cobalt deficiency. Onset of immunity: 14 days after the primary vaccination course (2 doses) Duration of immunity: 12 months Net Contents: 250 doses 250 mL, 500 doses 500 mL Directions for Use: Restraints: Contraindications: Precautions: Side Effects: Transient l ocalised swelling will develop at the site of injection. In a small number of cases a small nodule may persist for some weeks or even months. RLP APPROVED For Official Use Only Dosage and Administration: This section contains file attachment. General Directions: This section contains file attachment. Withholding Periods: MEAT: Zero (0) days MILK: Zero (0) days Trade Advice: E xport S laughter I nterval (ESI): Zero (0) days Safety Directions: First Aid Instructions: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126. First Aid Warnings: Additional User Safety: Take care to avoid self-injection. In the event of self-administration, seek medical attention if you are concerned. Show the pack Lire le document complet